Taskin Ahmed
Jun 8, 2009
Citations
0
Influential Citations
0
Citations
Journal
Journal name not available for this finding
Abstract
Concert Pharmaceuticals and GlaxoSmithKline (GSK) are to collaborate on the development of deuterium-containing drugs, including CTP-518, a deuterated version of Bristol-Myers Squibb’s HIV protease inhibitor, atazanavir. GSK may be onto a winner here with this unique technology, which has the potential to improve the metabolic properties of drugs, and result in new formulations of existing drugs.